Inhibition of relaxations to nitrergic stimulation of the mouse anococcygeus by duroquinone
Open Access
- 1 December 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 116 (8) , 3231-3236
- https://doi.org/10.1111/j.1476-5381.1995.tb15129.x
Abstract
1 The role of copper/zinc superoxide dismutase (Cu/Zn SOD) in protection of nitrergic neurotransmission in the mouse anococcygeus was investigated by use of duroquinone (DQ), which generates superoxide anions within tissues via reduction by flavoprotein enzymes. 2 In control anococcygeus muscles, DQ (10–100 μm) produced concentration-related inhibition (-log IC40=4.41) of relaxations to exogenous nitric oxide (NO; 15 μm). Nitrergic relaxations induced by field stimulation (10 Hz; 10 s train) were much less affected, 100 μm DQ reducing nitrergic relaxations by only 14 ± 6%. 3 Following incubation with the Cu/Zn SOD inhibitor, diethyldithiocarbamate (DETCA; 3 mM; 45 min incubation; 10 min washout), the inhibitory effects of DQ on relaxations to NO were potentiated (-log IC40 = 5.22), and clear, concentration-related inhibitions of nitrergic relaxations were now observed (-log IC40 = 4.54). In both cases, these inhibitions were partially reversed by Cu/Zn SOD (250 u ml−1). In DETCA-treated tissues, DQ (100 μm) also reduced relaxations to sodium nitroprusside (1 μm) and S-nitroso-glutathione (30 μm), but potentiated those to 8-Br-cyclic GMP (100 μm). 4 Neither hydroquinone (HQ; 100 μm) nor 1,4-benzoquinone (BQ; 100 μm), both of which reduced responses to exogenous NO, inhibited relaxations induced by field stimulation in DETCA-treated tissues. Indeed, when added during DQ-induced inhibition of nitrergic relaxations, both HQ and BQ produced partial reversal of the block. 5 DQ had no effect on the detection of superoxide anions estimated via the xanthine: xanthine oxidase chemiluminescence assay, or of authentic NO as measured by a chemical microsensor. However, the detection of both superoxide anions and NO in these assays was inhibited by inclusion of either HQ or BQ. 6 The results support the proposal that nitrergic transmission in the peripheral nervous system is protected by Cu/Zn SOD activity in the region of the neuroeffector junction, and this may explain the lack of effect of superoxide anion generating drugs such as DQ. Such an explanation does not hold for either HQ or BQ, which appear to be acting directly as free radical scavengers in these experiments.Keywords
This publication has 22 references indexed in Scilit:
- Duroquinone, benzoquinone and nitrergic relaxation of the mouse anococcygeus musclePharmacological Research, 1995
- Nitric Oxide as a Neurotransmitter in Peripheral Nerves: Nature of Transmitter and Mechanism of TransmissionAnnual Review of Physiology, 1995
- NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of superoxide dismutase with diethyldithiocarbamateNeuropharmacology, 1994
- Models of the diffusional spread of nitric oxide: Implications for neural nitric oxide signalling and its pharmacological propertiesNeuropharmacology, 1994
- NADPH-cytochrome reductase catalysed redox cycling of 1,4-benzoquinone; hampered at physiological conditions, initiated at increased pH valuesBiochemical Pharmacology, 1994
- Differential effects of hydroxocobalamin on relaxations induced by nitrosothiols in rat aorta and anococcygeus muscleEuropean Journal of Pharmacology, 1993
- Effect of LY 83583 on relaxation induced by non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundusEuropean Journal of Pharmacology, 1992
- NITRERGIC TRANSMISSION: NITRIC OXIDE AS A MEDIATOR OF NON‐ADRENERGIC, NON‐CHOLINERGIC NEURO‐EFFECTOR TRANSMISSIONClinical and Experimental Pharmacology and Physiology, 1992
- Inactivation of intracellular copper-zinc superoxide dismutase by copper chelating agents without glutathione depletion and methemoglobin formationFree Radical Biology & Medicine, 1989
- Relationship of the single-electron reduction potential of quinones to their reduction by flavoproteinsBiochemical Pharmacology, 1980